Mereo BioPharma Group plc Quarterly Liabilities, Current in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Mereo BioPharma Group plc quarterly Liabilities, Current history and growth rate from Q4 2022 to Q3 2024.
Mereo BioPharma Group plc Liabilities, Current for the quarter ending September 30, 2024 was $14.2M.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$14.2M			Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$15.5M			Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$11M			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$9.49M	-$14.9M	-61.1%	Dec 31, 2023	10-Q	2024-11-12
Q4 2022	$24.4M			Dec 31, 2022	10-K	2024-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.